Skip to content

Dr IMBERT

Active Private limited companyfounded 2015active for 11 yearsSchoon Verblijflaan 72, 1180 UccleKBO/BCE: BE 0632.781.280

Lifetime

11 annual accounts with figures on one time axis
peak of €591,428 in 2024
€574,297▼ 2.9%
peak of €415,067 in 2024
€400,940▼ 3.4%
peak of €129,156 in 2017
€20,460unchanged
€997,117▲ 38.5%
Board1 name since 2015
1 director
Documentsfilings and deeds
22-06-202639 days before the deadline
2025micro format
Dividend €400,940Debts from €719,715 to €997,117Cash from €154,562 to €449,676

Key points

from the 2025 annual accounts

Equity

€20,460 from €129,156 in 2017

Equity fell by 84% in 8 years.

Debts

€997,117 98% of the balance sheet
Financial debts 25%Suppliers 1%Taxes and wages 2%Other 72%

Of this, €748,022 falls due within a year.

Filings

11 annual accounts since 2015
AprilJune31 JulyOctober201520202025

The 2016 accounts came 31 days late. The other nine of the last ten were filed on time.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 537 companies had the same profile as Dr IMBERT has now. Each dot stands for 2 companies, two years later.

95.9%
were still trading
3.4%
stopped another way
0.7%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 537 companies, not a prediction for Dr IMBERT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • all the sharesdeed of 09-01-2023
Board & ownership

Recent changes

Amendment of the articles · Legal-form change · Resignations & appointments changes role from manager to director · holds all the shares · General meeting of 13-12-2022 · Gazette deed
Registered office moved to Uccle The registered office moved from Avenue des Sept Bonniers, 44 à 1180 - Uccle to Avenue du Beau Séjour 72, 1180 Uccle · General meeting of 03-10-2016 · Gazette deed
Incorporation Founding capital of €18,600, 186 shares · Founded by (associé unique) · appointed as manager · published on 30-06-2015 · Gazette deed
First establishment Schoon Verblijflaan 72, Uccle
All 18 events

Official details

Source: KBO
Status
Active since 26-06-2015Normal situation
Activity
“La société a pour objet l’exercice de la médecine,et plus spécifiquement de la gynécologie-obstétricien,au…” (deed in French)From the articles, 12 activities1 activity on the establishment unit
Establishment unit
2.243.481.1281180 Uccle, since 26-06-2015
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

≈ €1.2mestimated
€1.0m▲ 37.5%
Filing
Filed on 22-06-2026, 39 days before the end of the filing period
Financials

Insights on Dr IMBERT

Dr IMBERT files the micro format. That format states no turnover. The gross margin rose from €21,837 in 2015 to €574,297 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr IMBERT

What is the company number of Dr IMBERT?
The company number of Dr IMBERT is 0632.781.280. The VAT number is the same number with BE in front: BE 0632.781.280.
Where is Dr IMBERT based?
The registered office is at Schoon Verblijflaan 72, 1180 Uccle.Company details
What is the legal form of Dr IMBERT?
Dr IMBERT is a private limited company (BV).
When was Dr IMBERT founded?
Dr IMBERT was founded on 26-06-2015.
Is Dr IMBERT still active?
Yes, Dr IMBERT is an active enterprise in the KBO register.
What is the turnover of Dr IMBERT?
The turnover in financial year 2025 is ≈ €1.2m. This figure is estimated from the gross margin of €574,297 and 1,019 comparable companies of the same size. It probably lies between €800,000 and €1.7m. It is a rough estimate.Financials
Is Dr IMBERT profitable?
In financial year 2025, Dr IMBERT made a profit of €400,940.
Where can I find the annual accounts of Dr IMBERT?
Dr IMBERT filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr IMBERT due?
Dr IMBERT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.